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[57] ABSTRACT 
This invention relates to a self-expanding intraluminal com-
posite prosthesis comprised of a rigid reinforcing component 
and sealing component. The prosthesis may be fabricated as 
either a straight or bifurcated tubular structure and is appli-
cable to the treatment of any bodily passage including, but 
not limited to, vascular applications, e.g., aneurysms, arte-
riovenous fistulas. as well as stenotic regions of the periph-
eral circulation which have been percutaneously dilated but 
are at high risk for restenosis. The major attributes of this 
prosthesis can include the use of a unique multilayered 
biaxial braid which thereby creates a homogeneously 
blended composite with isotropic deformation and expan-
sion characteristics and an associated high contraction ratio. 
The use of multiple layers allows for the fabrication of a 
device of varied porosity while retaining adequate tensile or 
mechanical wall strength. 
22 Claims, 2 Drawing Sheets 
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ability to produce devices of smaller cross-sectional area 
(flow profile) is its major advantage. Nonetheless, it has two 
major disadvantages. Nitinol requires irrigation with cold 
saline solution during placement to prevent premature This application is a continuation of application Ser. No. 
08/131,156, filed Oct. 1. 1993 which status is abandoned. 
BACKGROUND OF THE INVENTION 
1. Field of the Invention 
5 expansion. Additionally, its anisotropic expansion may 
cause damage to the vascular wall. 
This invention relates to intralurninal prosthetic devices. 
Most stent delivery systems are based on multi-sheath 
catheters. Self-expanding stents are deployed when the outer 
sheath of the catheter is retracted. The stent expands and the 
In particular, this invention relates to self-expanding intralu-
rninal composite prosthetic devices for use, e.g., in endo-
vascular applications. 
2. Background Art 
10 catheter is withdrawn. Balloon expandable stents are seated 
on an angioplasty balloon. After the sheath is removed, the 
balloon is inflated to deploy the stent. Catheter delivery 
systems have only recently been used to deploy grafts, but 
Since 1975, vascular prostheses composed of either knit- 15 
ted or woven Dacron® fibers or expanded PTFE (Gore-
Tex®) have been established standards in anastomotic sur-
gical arterial reconstruction. In the past decade, however, a 
steady growth of non-surgical transcatheter techniques and 
related devices have broadened both potential applications 
and overall suitability of endovascular reconstruction. In 
particular, angioplasty with or without endovascular stent 
placement has become an accepted adjunct in the manage-
ment of atherosclerotic occlusive disease. 
20 
follow the same principles outlined above. 
Commercially available vascular grafts for surgical appli-
cations are typically composed of polyethyleneterepthalate 
(DACRON®) fibers or extruded polytetrafiuoroethylene 
(GORE-TEX®). Woven andknitted grafts are crimped in an 
accordion-like fashion along their circumference to prevent 
"kinking" when traversing curves or bends. Mechanistically, 
In the past, aneurysmal aortic disease has been treated 
almost exclusively by resection and surgical graft place-
ment. Recently, however, successful preliminary tests have 
been reported for transfemoral endovascular grafting as an 
alternative therapeutic option. In contrast to standard surgi-
crimping allows the graft to expand longitudinally but limits 
radial contraction. Weave patterns and their associated 
porosity and handling characteristics for sutured anasto-
moses remains the major difference among graft types (see. 
25 Durnicans, U.S. Pat. No. 4,923,470; and Kaster, U.S. Pat. 
30 
No. 4,441,215). Such devices are not suitable for endovas-
cular applications although woven and knitted DACRON® 
grafts have been tried for endovascular grafting. Crimping 
appears necessary to reduce kinking but Emits the com-
pressibility and cross-sectional flow profile of the device. 
The incorporation or "healing" of a fabric-based vascular 
prosthesis may depend, in part, on an optimal porosity of the 
prosthesis (see, Snyder, R. W. and Botzko, K. M. from 
cal repair. the use of an endovascular device does not entail 
the removal of the diseased aorta. but serves to create a 
conduit for blood flow in the event of subsequent aneurysm 
rupture. It has been postulated that an endovascular graft 
may. as a secondary effect, lower the rate of aneurysm 
expansion and late rupture via a reduction of hemodynami-
cally induced wall stresses. Endovascular aortic prostheses 
under current commercial development consist almost 
exclusively of grafts and stents attached together to form a 
single device. The stent secures the graft in a desired 
position and reduces the risk of late prosthetic migration. 
35 Biologic and Synthetic Vascular Prosthesis, edited by J. C. Stanley, Grune and Stratton: New York, (1982), pp. 
485-494; and Turner, R. J., Hoffman, H. L., Weinburg, S. L. 
from Biologic and Synthetic Vascular Prostheses, edited by 
J. C. Stanley, Grune and Stratton: New York, (1982), pp. 
40 509-522). Wesolowski and co-workers reported that 
increased porosity was associated with a reduction in graft 
calcification (Wesolowski, S. A., Liebig, W. J., Karlson, K. 
E., et al., Surgery, 50, 91-100 (1961)). As an outgrowth of 
this work, the vascular graft industry pursued, for a time, the 
There are presently two classes of stents in widespread 
clinical use categorized with respect to their mode of expan-
sion: balloon expandable and self expanding. Balloon 
expandable stents typically consist of slotted or wire mesh 
tubes that can be permanently expanded after operator 
controlled balloon inflation. At least four U.S. patents have 
been granted (see, Palrnaz: U.S. Pat. Nos. 4,739,762; 4,739, 
762; 4,776.337; and 5,102,417 and Strecker, E. P.; 
Llermann, D.; Barth, K. H.; Wolf, H. R. D.; Freudenberg, N.; 
Berg. G.; Westphal, M.; Tsikuras, P.; Savin, M.; and 50 
Schneider, B., Radiology, 175. 97-102 (1990)). 
Characteristically, self-expanding stents are loose wire 
meshes that can be compressed inside a sheath which, when 
removed, allows the stent to expand without the use of an 
inflating balloon. Many models are in common use includ- 55 
ing the MEDINVENT® stents, (see, Jedwab, M. R. and 
Clerc, C. 0. J. Appl. Biomater, 4, 77-85 (1993) and 
Gianturco, Yoshioka, T.; Wright, K.; Wallace, S.; Lawrence 
Jr .. D. D.; Gianturco, C. Amer. J. Radiology, 151. 673--076 
(1988)). 
Recently, Nitinol has been suggested as an alternative to 
stainless steel which has been the standard stent fabrication 
material (see, Balko, A.; Piasecki, G. J.; Shah, D. M.; 
Carney, W. I.; Hopkins. R. W. and Jackson. B. T., J. Surg. 
Res., 40, 305-309 (1986)). This nickel titanium alloy. also 
called "memory metal", will assume its original annealed 
shape when heated above a particular temperature. The 
45 goal of an ultrathin. highly porous graft. This approach was 
abandoned after mechanical failure plagued these grafts 
(see, Ottinger. L. W. Darling, R. C. Werthlin, L. S .. et al., 
Arch. Surg. 111. 146-149 (1976)). 
Sutureless grafts for vascular reconstruction were 
reported and patented as early as the 1960' s as an alternative 
to standard operative aortic repair. In the 1980's, percuta-
neous transcatheter techniques grew in popularity and the 
concept of sutur~less grafting was reintroduced as an endo-
vascular approach to occlusive and aneurysmal disease. A 
triple layered air-inflatable graft has been patented, but the 
potential for failure appears substantial because of the 
complex arrangement of membranes, valves, and seals 
(Pigott, U.S. Pat. No. 5,156,620). Sutureless endovascular 
prostheses have otherwise included: (i) graft/staple; (ii) 
60 graft/hook; and (iii) graft/stent combinations. 
Graft/staple combinations are covered by two U.S. patents 
in which a balloon catheter system delivers a standard 
vascular graft with staples lodged in the end of the graft 
(Lazaras. U.S. Pat. Nos. 4,787 .899 and 5,104,399). The 
65 inflation of the balloon implants the staples into the vascular 
wall, thereby securing the graft. 1\vo additional patents exist 
for graft/hook combinations (Kornberg, U.S. Pat. Nos. 
5,741,325 
3 
4,562.596 and 4,617 ,932). Angled hooks on the proximal 
portion of the graft secure it in place. These grafts may be 
expanded either mechanically or with the use of flexible 
self-expanding rings. 
Currently, most approaches follow the graft/stent concept 5 
and can be further classified as: (i) fabric or membrane 
covered stents; ;(ii) grafts bridged by stents (Rhodes, U.S. 
Pat. No. 5.122.154); and (iii) stents bridged by a graft. Most 
commercial efforts have focused on the latter of these three 
approaches. Based on earlier work by Parodi. Johnson & 10 
Johnson is developing a prosthesis comprised of a woven 
DACRON® tube graft connected to a balloon expandable 
Palmaz-type stent. The Cook Corp. is investigating the use 
of self-expanding Gianturco stents in association with a 
bifurcated graft. This is an extension of studies performed by 15 
Green. Endovascular Technologies (EVT) of California has 
placed a hook containing self-expanding ring at the proximal 
end of a vascular graft. This prosthesis is essentially a 
combination of the Rhodes and Kornberg inventions. 
Finally. the Meditech Corporation is evaluating a fabric 20 
covered balloon expandable Strecker stent. The stent con-
sists of interlocked tantalum wires. 
4 
optimal porosity and mechanical stability by blending a 
reinforcing component with the sealing components typi-
cally used in vascular grafts. In one embodiment, fue use of 
multiple layers allows for the fabrication of a device of 
varied porosity while retaining adequate tensile or mechani-
cal wall strength. By increasing the number of layers, the 
porosity can be reduced for high risk or heparin treated 
patients. 
Specifically, the present invention provides a self-
expanding intralurninal composite prosthesis, comprising an 
elongated tubular shaped member having a body portion that 
is formed by at least one layer of a composite material 
comprised of a plurality of strands of a reinforcing fiber and 
a plurality of strands of a sealing fiber. The fibers comprising 
the body portion can be interwoven, e.g., in a unique 
biaxially braided design. The tubular shaped member has an 
expanded diameter, a radially contracted diameter, and an 
operable diameter which is intermediate the expanded and 
radially contracted diameters. The tubular shaped member 
can be compressed radially along its longitudinal axis to 
permit intralurninal delivery of the tubular shaped member 
through a body passage to a predetermined delivery site 
wherein the tubular shaped member self-expands upon 
deployment within the body passage to its operable diam-
eter. The reinforcing fiber can be comprised of a material 
However, these devices may experience mechanical fail-
ure due to stress concentration at the point of attachment or 
due to the lack of mechanical stability along the long axis of 
the graft portion of the device. Therefore. there still exists a 
need for an endovascular graft that provides optimal poros-
ity yet retains mechanical integrity. 
25 selected from the group consisting of biocompatable metals, 
polymers, and organic fibers. The sealing material can be 
any biocompatable polymer including, but not limited to, 
polyethyleneterepthalate, polytetrafluoroethylene, 
SUMMARY OF THE INVENTION 
It is an object of the present invention to provide a 
superior intraluminal prosfuetic device which has the fol-
lowing qualifies: 
1. A device that can be easily transported in any body 
passage, e.g., to an aneurysm (or region of arterial 
disease or injury) via endovascular means so as to 
avoid invasive surgical techniques. 
2. A device that can be easily deployed without damaging 
vascular tissue. 
3. A device that easily fits into curved blood vessels, while 
retaining sufficient mechanical integrity to contain pul-
satile blood flow. 
30 
polysiloxane, and nylon or any biocompatable carbon fibers. 
In one embodiment, the invention provides a self-
expanding intralurninal composite prosthesis wherein the 
tubular shaped member further comprises a first end portion 
and an opposing second end portion with the body portion 
interconnecting the end portions. At least one of the end 
35 portions has an expanded resting diameter that is larger than 
the expanded resting diameter of the body portion such that 
the larger diameter end portion exerts a force upon the 
luminal surface of the body passage sufficient to anchor the 
tubular shaped member at a predetermined delivery site. The 
40 end portions can be formed from a single layer of the 
biaxially braided interwoven reinforcing and sealing fibers 
or, alternatively, from a single layer of a biaxially braided 
interwoven reinforcing fiber. 
4. A device that minimizes the concentration of stress 45 
which can lead to mechanical failure. 
In another embodiment, one end portion contains a seg-
ment which is sufficiently porous such that placement of the 
segment at the intersection of a branch in the body passage 
allows bodily fluids to pass through the segment and into the 
branches of the body passage, thereby maintaining fluid 
5. A device that is able to treat arterial malfunctions in the 
vicinity of arterial or aortic branches. 
6. A device that is designed to treat aneurysms or arterial 
disease in the vicinity of bifurcated blood vessels. 
The present invention overcomes the deficiencies of the 
prior art by providing a porous, self-expanding intralurninal 
composite prosthesis comprised of a rigid reinforcing com-
ponent and sealing component. The prosthesis may be 
fabricated as either a straight or bifurcated tubular structure 
and is applicable to fue treatment of any bodily passage 
including, but not limited to, vascular applications, e.g., 
aneurysms, arteriovenous fistulas, as well as stenotic regions 
of the peripheral circulation which have been percutane-
ously dilated but are at high risk for restenosis. The major 
attributes of this prosfuesis can include the use of a unique 
multilayered biaxial braid which thereby creates a homoge-
neously blended composite with isotropic deformation and 
expansion characteristics and an associated high contraction 
ratio. 
The composite layered design of the present invention 
also satisfies a need in the art by providing a prosthesis wifu 
50 
communication between the body passage and the branch. 
In a further embodiment, the invention provides a self-
expanding intraluminal composite prosthesis that is suitable 
for placement in a bifurcated body passage. The body 
portion of the prosfuesis is bifurcated forming two branches 
having expanded diameters that are less than the expanded 
55 diameter of the body portion proximal to the bifurcation. 
In a preferred embodiment, the present invention provides 
a self-expanding intralurninal composite prosfuesis specifi-
cally designed for endovascular applications. 
The present invention also provides a mefuod for treating 
60 aortic aneurysmal disease. Also provided is the device of the 
present invention mounted on a delivery catheter within a 
removable sheath located on the catheter. 
65 
BRIEF DESCRIPTION OF THE FIGURES OF 
THE DRAWINGS 
FIG. 1 is a side view of the interwoven fibers of a segment 
of fue single layer of fue body portion of the prosthesis. 
5,741,325 
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FIG. 2 is a side view of the prosthesis in radial compres-
sion. 
FIG. 3 is a side view of one embodiment of the invention. 
FIG. 4 is a side view of the prosthesis deployed within a 
vertical cross-section of in an aortic aneurysm. 5 
FIG. 5 is a side view of one embodiment of the prosthesis 
deployed within a vertical cross-section of an aneurysm and 
an aortic branch. 
6 
operable diameter when deployed in a body passage 14 
which is intermediate the expanded and radially contracted 
diameters, the tubular shaped member 2 being radially 
compressible along its longitudinal axis between the 
expanded and radially contracted diameters to permit 
intralurninal delivery of the tubular shaped member 2 
through a body passage 14 to a predetermined delivery site 
16. At the predetermined delivery site 16, the tubular shaped 
member can self-expand within the body passage 14 to its 
FIG. 6 is a top view of one embodiment of the prosthesis 
having a bifurcated body portion. 
10 operable diameter as shown in FIGS. 4-5. 
DEI'AILED DESCRIPTION OF THE 
INVENTION 
In a preferred embodiment, the invention provides a 
self-expanding intralurninal composite prosthesis 10. 
wherein the composite material 6 is interwoven in a biaxi-
ally braided design as shown in FIG. 1. The biaxial braid 
The present invention may be understood more readily by 
reference to the following detailed description of specific 
embodiments and the Examples and Figures included 
therein. 
15 (diamond braid) design is a one over one configuration. It is 
contemplated by the invention that other braids such as a 
regular two over two braid or a hercules three over three 
braid can be utilized. 
As used in the claims, "a" means one or more. 
The present invention provides a true composite device 
that possesses the structural and mechanical reinforcing 
characteristics of a stent with the containment characteristics 
20 
of a graft. A "composite" as used herein refers to two 
components, e.g., the reinforcing and sealing components 
25 that are blended rather than two devices that are attached. 
Blending of components can be achieved by any of a number 
of means including, but not limited to, interweaving the 
component fibers to fo:rnl a composite structure. 
The device of the present invention consists of a mechani- 30 
cally stiff component that is blended with a more compliant 
component, the combination of which is fabricated as a 
straight or branched tubular structure. The stiff component 
provides mechanical resistance such that any radial defor-
mation of the tube requires some force. Further, the elastic 35 
deformation characteristics of the two components can be 
identical such that deformation of the device (for delivery or 
deployment) occurs in an isotropic fashion so as to avoid 
internal stress gradients that may cause the two components 
to separate. The composite nature of the device homoge- 40 
neously distributes these forces so as to minimize the 
possibility of device failure. This is in contrast to the 
assembly of two separate devices (such as a graft and a stent) 
where the stress is concentrated in whatever means is used 
to fasten the two devices together. The isotropic expansion 45 
characteristics possessed by the present invention also mini-
mize the damage to vascular tissue that potentially occurs 
with other devices such as a Nitinol stent. 
Although braiding of the components comprises the pre-
ferred embodiment of the device, blending of any two 50 
components that possesses these consistent deformation 
characteristics may be used. Other possible composite sys-
tems include an expanding metal mesh protruded in a 
tubular form with a polymeric matrix that is subsequently 
cross-linked. by chemical, radiative or other means to form 55 
an elastomeric matrix with deformation characteristics con-
sistent with those of the metal mesh. 
The reinforcing fibers 8 can be comprised of any biocom-
patable material including, but not limited to, metals. 
polymers, organic fibers or combinations thereof. The seal-
ing fibers 12 can be comprised of any biocompatable poly-
mer or carbon fiber. Examples of suitable polymers include, 
polyethyleneterepthalate, polytetrafluoroethylene, 
polyurethane, polysiloxane or nylon. 
Preferrably, the diameter of the fibers 8.12 is between 
about 0.1 mm and 0.5 mm. A single layer of the composite 
material 6, as shown in FIGS. 1-2, is normally porns and the 
pore size 40 is between about 0.5 mm and 2.5 mm. The pore 
size 40 in the biaxial braid design can be varied by adjusting 
the number of sealing fibers 12 per layer, the diameter of the 
reinforcing and sealing fibers 8,12, the distance between the 
fibers 8,12. and the angle formed where the fibers intersect 
each other at the point of interlock 42. The angle formed by 
the fibers 8, 12 at the point of interlock 42 can range between 
about 60° and 130°, but the preferred angle is about 90° 
when the tubular shaped member 2 is at its expanded 
(resting) diameter. The contraction ratio for the prosthesis of 
the present invention can range from between about 3 and 
10. A presently preferred ratio is about 5. 
In one embodiment, the self-expanding intraluminal com-
posite prosthesis 10 of the invention is constructed from 
reinforcing and sealing fibers 8,12 that have substantially 
similar elastic deformation characteristics, thereby permit-
ting isotropic deformation, e.g., radial compresion of the 
tubular shaped member 2 as shown in FIG. 2. 
As shown in FIGS. 3-6, the tubular shaped member 2 of 
the present invention can further comprise a first end portion 
18 and an opposing second end portion 20 with the body 
portion 4 interconnecting the end portions 18,20. It is 
contemplated by the invention that at least one (or both) of 
the end portions 18,20 can have an expanded diameter that 
is larger than the expanded diameter of the body portion 4 
and an operable diameter, such that the larger diameter end 
portion(s) 18,20 exerts a force upon the lurninal surface 22 
of the body passage 14 at its operable diameter sufficient to 
anchor the tubular shaped member 2 at the predetermined 
delivery site 16 as shown in FIGS. 4-5. The end portions 
Referring now to the figures, the present invention pro-
vides a self-expanding intraluminal composite prosthesis 10. 
comprising an elongated tubular shaped member 2 having a 
body portion 4, the body portion 4 being formed by at least 
one layer of a composite material 6. the composite material 
6 being comprised of a plurality of strands of a reinforcing 
fiber 8 and a plurality of strands of a sealing fiber 12. The 
fibers 8.12 are interwoven. thereby forming the composite 
material 6. The tubular shaped member 2 has an expanded 
or resting diameter. a radially contracted diameter. and an 
60 18.20 can be constructed from materials selected from the 
group consisting of a single layer of the composite material 
6 or from a single layer of the interwoven reinforcing fiber 
8. In a preferred embodiment, the invention provides at least 
one of the end portions 18.20 in an interwoven biaxially 
65 braided design as shown in FIG. 3. 
Referring now to FIG. 5, the present invention also 
provides a self-expanding intralurninal composite prosthesis 
5,741,325 
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10, wherein the first end portion 18 is longer than the second 
end portion 20 and at least a segment 24 of the first end 
portion 18 is sufficiently porus such that placement of the 
segment 24 at the intersection of a branch 26 in the body 
passage 14 allows bodily fluids to pass through the segment 5 
24 and into the branches 29,31 of the body passage 14, 
thereby maintaining fluid communication between the body 
passage 14 and the branches 29,31. 
layers may consist of sealing fibers 12, reinforcing fibers 8, 
or both of these components braided together. The biaxial 
braid shown in FIG. 1, typically called a diamond braid, 
comprises single oppositely wound strands crossing each 
other. The numbers of the strands that cross each other may 
be varied as long as all of the layers of the device contain a 
consistent braiding pattern. 
The biaxial nature of the braid allows the device to be 
compressed significantly to be delivered endovascularly via The prosthesis provided by the present invention can be 
used in any hollow body passage including, but not limited 
to, arteries, veins, bile ducts, and the like. In a preferred 
embodiment, the prosthesis of the present invention is 
designed for endovascular applications as shown in FIGS. 
4-5. In those figures, the prosthesis 10 is deployed in a blood 
vessel 30 at a predetermined delivery site 16 which is an 
aneurysm 32. 
Referring now to FlG. 6, shown is an alternate embodi-
ment of the self-expanding intraluminal composite prosthe-
sis of the present invention wherein the body portion 4 is 
bifurcated along a part of its length forming two branches 
34,36 such that the two branches 34.36 have an expanded 
diameter that is less than the expanded diameter of the body 
portion 4 proximal to the bifurcation 38. This embodiment 
forms a Y-shaped intraluminal prosthesis for placement in a 
bifurcated body passage (not shown). 
The present invention also provides the self-expanding 
intraluminal composite prosthesis 10 mounted on a delivery 
catheter (not shown) within a removable sheath (not shown) 
located on the catheter. Also provided is a method for 
treating aortic aneurysmal disease comprising delivering the 
prosthesis provided by the present invention to a predeter-
mined delivery site 16. Briefly, the prosthesis (mounted on 
a standard delivery catheter inside a sheath under radial 
compression) is inserted into the body passage and advanced 
along the passage to the predetermined delivery site 16. The 
prosthesis is deployed by retracting the sheath proximally 
along the long axis of the delivery catheter such that the 
prosthesis is uncovered. This removes the radially compres-
sive forces exerted by the sheath and allows the prosthesis 
to self-expand to its operable diameter. 
EXAMPLES 
Referring again to FIG. 1, the preferred embodiment of 
the device is designed for endovascular applications and 
consists of a stiff reinforcing fiber 8, possibly of wire or a 
thermoplastic or thermoset polymer resin biaxially braided 
into a tubular structure with strands of a less stiff sealing 
fiber 12. Strands of the less stiff sealing fiber 12 form a 
sealed or semiporous structure to contain blood flow while 
the stiff reinforcing fiber provides structural reinforcement. 
These sealing strands can typically be made of synthetic or 
natural fiber that have been approved for devices such as 
DACRON®. A biaxially braided tubular structure can con-
sist of an even number of filaments or strands wound in a 
helical fashion around a center longitudinal axis as seen in 
FIG. 1. Half of the strands (fibers 8,12) are wound in one 
direction. while the other half are wound in the other 
direction. The oppositely wound strands alternate passing 
over and under each other, each time their paths cross (the 
point of intersection 42) so as to form a mechanically stable 
intermeshed network The body portion 4 can consist of 
multiple layers of the braided tube as shown in FIG. 1. These 
layers can be comprised of a minimum number of strands to 
provided mechanical stability (typically 8) up to whatever 
number is necessary to fabricate a tube of sufficient diameter 
for the particular body passage, e.g., a blood vessel. The 
10 a catheter type device. When compressed, the various layers 
of the device will appear as seen in FlG. 2. Other types of 
braids such as triaxial braids that contain reinforcing warp 
strands woven parallel to the longitudinal axis may prevent 
the device from contracting sufficiently. However, it is 
15 contemplated by the present invention that wires may be 
used in place of these warp strands such that the biaxially 
braided strands slide along these wires wherein both con-
traction of the device and additional longitudinal stability 
may still occur. If used, warp strands may only be used over 
20 a small portion of the device. Otherwise, the device's 
inherent ability to bend is lost. It is the inherent ability of the 
device to contract longitudinally that allows it to bend. A 
bend is achieved by contracting one side more than the other. 
However. unlike extruded grafts, the biaxial braid design 
25 prevents the device from collapsing. 
The distance between the interlocking braided strands of 
fiber 8, 12 in FIG. 1 determines the degree to which the 
device may contract for catheter delivery. The larger this 
distance is, when the device is in its equilibrium or stress-
30 free conformation (the expanded diameter), the more con-
traction the device can undergo until the inner diameter of 
the cylinder approaches zero. In the preferred embodiment, 
the contraction ratio to best facilitate catheter deployment is 
approximately five. This requires that the distance between 
35 the wires be approximately 5 times the width of the rein-
forcing or sealing fibers used in the braid, when the angle 
between the fibers is 90°. Depending upon the application, 
this space may make the device too porous to seal, e.g., an 
aneurysm or other type of vascular wall trauma subjected to 
40 arterial blood flow and the associated pressures. Typical 
values of the reinforcing or sealing fiber 8, 12 diameter are 
in the range from 0.1 to 0.5 mm. This leaves pores in the 
body portion 4 from 0.5 to 2.5 mm. As a consequence, layers 
of the braided composite material 6 are required for par-
45 ticular endovascular embodiments of the device. Sufficient 
layers may be used to reduce the porosity to an acceptable 
level, while each layer still possesses a contraction ratio 
sufficient to allow catheter delivery. If the distance between 
the braided strands (fibers 8, 12) in a single layer design (as 
50 shown in FIGS. 1-2) is reduced to provide a porosity 
sufficient to seal the device with respect to arterial blood 
pressure, the device will not contract sufficiently for catheter 
delivery. 
The original angle of the reinforcing and sealing compo-
55 nents of the composite will determine the expanded or 
resting diameter of the device under the equilibrium or a 
zero stress condition. The prosthesis of the present invention 
can be configured such that it can be compressed radially by 
applying an inward radial stress whereby these angles 
60 approach 180° near the condition of maximum compression 
(the radially contracted diameter), as seen in FlG. 2. This 
conformation is adopted when the device is mounted on a 
catheter (not shown) to be used for endovascular delivery of 
the device. A flexible tubular sheath (not shown). with very 
65 low radial compliance, comprising part of the catheter 
delivery system, provides the radial stress necessary to hold 
the device in this conformation. This stress is applied 
5,741,325 
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normally to the surface of the device to achieve the confor-
mation seen in FIG. 2. Once the device is positioned in the 
body passage 14, e.g., a blood vessel. the sheath is removed 
and the graft expands to its operable diameter which is less 
than the expanded or resting diameter. Because the diameter 
of the device when deployed (the operable diameter) is less 
than the expanded diameter, the device exerts a radial stress 
normal to the inner surface of the blood vessel. It is this 
normal force that holds the device in place. 
One embodiment of the present invention provides addi-
tional means for securing the device in place wherein the 
reinforcing components (fibers 8) of the composite extend 
along the longitudinal axis further than the sealing compo-
nents (fibers 12) as shown in FIG. 3. The layer or layers of 
the composite material (interwoven reinforcing and sealing 
components) comprise the body portion 4 of the device. The 
extension of the stiffer reinforcing wires beyond the body 
portion 4 provides additional means for securing the device 
in the blood vessel. The expanded diameter of the end 
portions 18,20 of the tubular shaped member 2 may be 
increased somewhat over the body portion 4 of the prosthe-
sis 10. This increase in diameter allows the reinforcing 
component of the device to lodge into the blood vessel wall 
providing additional protection against the migration of the 
device (as shown in FIGS. 4-5). 
The deployment of the device to seal an aneurysm is seen 
in FIGS. 4-5. The body portion 4 of the prostheses 10 will 
eventually clot to seal the blood flow away from dilated 
blood vessel portion comprising the aneurysm 32. The 
prostheses is held in place by the normal force exerted on the 
proximal and distal ends of the aneurysm 32. The reinforc-
ing fibers 8 that extend beyond the sealing fibers 12 of the 
body portion 4 assist in securing the prosthesis. The 
increased diameter at the end portions 18,20 of the prosthe-
ses 10 help lodge the device into the vascular wall 22. 
In one embodiment, the device of the present invention 
may be used in the vicinity of blood vessel branches 29,31. 
This is accomplished by adjusting the position of the pros-
thesis 10 such that the branches 29,31 are covered by the 
segment 24 of the first end portion but not the body portion 
18 as seen in FIG. 5. Blood will flow through the highly 
porous mesh of the segment 24, but not the body portion 4. 
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be delivered by compressing it within a single catheter 
sheath (not shown) for endovascular delivery. Facilitation of 
its correct placement may require the use of multiple 
sheaths. The ends of the smaller separate branches 34,36 
5 may be compressed into smaller sheaths which may in turn 
be inserted into a larger sheath with the compressed main 
part of the body portion 4 of the bifurcated prosthesis 10. 
Although the present invention has been described with 
reference to specific details of certain embodiments thereof, 
10 it is not intended that such details should be regarded as 
limitations upon the scope of the invention except as and to 
the extent that they are included in the accompanying 
claims. 
What is claimed is: 
1. A self-expanding intralurninal composite prosthesis, 
15 comprising: an elongated hollow tubular shaped member 
having a body portion, the body portion being formed by at 
least one layer of a composite material, the composite 
material being comprised of a plurality of strands of a 
reinforcing fiber and a plurality of strands of a sealing fiber, 
20 wherein the fibers are interwoven in a biaxially braided 
design thereby forming the composite material that is 
capable of isotropic deformation along its longitudinal axis, 
the hollow tubular shaped member having an expanded 
diameter, a radially contracted diameter, and an operable 
25 diameter which is intermediate the expanded and radially 
contracted diameters, the tubular shaped member being 
radially compressible along its longitudinal axis between the 
expanded and contracted diameters to permit intralurninal 
delivery of the tubular shaped member through a body 
30 passage to a predetermined delivery site wherein the tubular 
shaped member can self-expand within the body passage to 
its operable diameter. 
2. The self-expanding intralurninal composite prosthesis 
of claim 1, wherein the composite material is interwoven in 
35 a biaxially braided design. 
3. The self-expanding intralurninal composite prosthesis 
of claim 1, wherein the reinforcing fiber is comprised of a 
material selected from the group consisting of biocompat-
able metals, polymers, organic fibers and combinations 
40 thereof. 
lf the aneurysm or region vascular disease completely 
encompasses the branching vasculature, treatment can be 
effected by using the bifurcated form of the device described 45 
below. 
4. The self-expanding intralurninal composite prosthesis 
of claim 1, wherein the sealing fiber is selected from the 
group consisting of a biocompatable polymer and a carbon 
fiber. 
5. The self-expanding intralurninal composite prosthesis 
of claim 3, wherein the polymer is selected from the group 
consisting of polyethyleneterepthalate, 
polytetrafluoroethylene, polyurethane, polysiloxane and 
nylon. 
A common configuration of major blood vessels is the 
bifurcation. This occurs when a blood vessel splits into two 
separate vessels such as at the aortic bifurcation. Treatment 
of pathology at bifurcated areas requires that under certain 50 
conditions the composite device is fashioned as seen in FIG. 
6. The main body portion 4 of this form of the prosthesis 10 
consists of the interbraided, interlayered reinforcing and 
sealing components (fibers 8,12). As with the aforemen-
tioned description, the end portions 18,20 can consist of the 55 
braided reinforcing component (fiber 8) with a gradually 
increasing diameter so as to facilitate secure placement of 
the prosthesis 10. The bifurcation 38 can be created by either 
6. The self-expanding intralurninal composite prosthesis 
of claim 1, wherein the reinforcing and sealing fibers have 
substantially similar elastic deformation characteristics, 
thereby permitting isotropic deformation of the tubular 
shaped number. 
7. The self-expanding intralurninal composite prosthesis 
of claim 1, wherein the tubular shaped member further 
comprises a first end portion and an opposing second end 
portion, the body portion interconnecting the end portions, 
and wherein at least one of the end portions has an expanded of a number of processes such as separately braiding half of 
the reinforcing fibers 8 in the body portion 4 of the device 
into separate branches (or limbs) 34,36 containing half as 
many reinforcing fibers 8. Such a design facilitates com-
pression of the entire device. Although the design of the 
reinforcing component is such that it will contract radially in 
a symmetric manner, the radial contraction may become 
asymmetric as the device approaches its maximum contrac-
tion ratio. Therefore, the entire bifurcated prosthesis 10 can 
60 diameter that is larger than the expanded diameter of the 
body portion and an operable diameter, such that the larger 
diameter end portion exerts a force upon the lurninal surface 
of the body passage at its operable diameter sufficient to 
anchor the tubular shaped member at the predetermined 
65 delivery site. 
8. The self-expanding intralurninal composite prosthesis 
of claim 7. wherein at least one of the end portions is 
5,741,325 
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co~prised of material selected from the group consisting of 
a smgle layer of the composite material and a single layer of 
the interwoven reinforcing fiber. 
9. The self-expanding intraluminal composite prosthesis 
of claim 8, wherein the material in at least one of the end 5 
portions is interwoven in a biaxially braided design. 
10. The self-expanding intraluminal composite prosthesis 
of claim 7, wherein the first end portion is longer than the 
second end portion and at least a segment of the first end 
portion is sufficiently porous such that placement of the 10 
segment at. an in~ersection of a branch in the body passage 
allows bodily flmds to pass through the segment and into the 
branches of the body passage thereby maintaining fluid 
communication between the body passage and the branch. 
11. The self-expanding intraluminal composite prosthesis 1s 
of claim 1. wherein the body passage is a blood vessel. 
12. The self-expanding intraluminal composite prosthesis 
of claim 11. wherein the blood vessel is an artery and the 
predetermined delivery site is an aneurysm. 
13. The self-expanding intraluminal composite prosthesis 20 
of claim 1, wherein the body portion is bifurcated along a 
part of its length forming two branches such that the two 
branches have an expanded diameter that is less than the 
expanded diameter of the body portion proximal to the 
bifurcation, thereby forming a Y-shaped intraluminal pros- 25 
thesis for placement in a bifurcated body passage. 
14. The self-expanding intraluminal composite prosthesis 
of claim 1, wherein a diameter of the fibers is between about 
0.1 mm and 0.5 mm. 
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15. :nie self-exp.anding intralurninal composite prosthesis 
of clru.m 1. wherem the layer of the composite material is 
porous and the pore size is between about 0.5 mm and 2.5 
mm. 
16 . . The self-expanding intraluminal composite prosthesis 
of clru.m 1, wherein a contraction ratio of the tubular shaped 
member is between about 3 and 10. 
17 . . The self-exJ?andin¥ intraluminal composite prosthesis 
?f chum 1, wherem the mterwoven biaxially braided fibers 
mtersect each other at a point of interlock and the angle 
formed by the fibers at the point of interlock is between 
about 60° and 130°, when the tubular shaped member is at 
its expanded diameter. 
18. The self-expanding intraluminal composite prosthesis 
of claim 1, wherein the body portion comprises a plurality 
of layers of the composite material such that the porosity of 
the body portion is maintained at a predetermined level. 
19. _The self-expanding intraluminal composite prosthesis 
of drum l, mounted on a delivery catheter within a remov-
able sheath located on the catheter. 
20. A method for treating aortic aneurysmal disease 
comprising delivering the device of claim 10 to the prede-
termined delivery site. 
21. The self-expanding intraluminal composite prosthesis 
of claim 16. wherein the contraction ratio is about 5. 
22. The self-expanding intraluminal composite prosthesis 
of claim 17, wherein the angle formed by the fibers at the 
point of interlock is about 90 degrees. 
* * * * * 
